-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $49

Benzinga·02/06/2026 15:32:05
Listen to the news
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $63 to $49.